Naltrexone

( DrugBank: Naltrexone / KEGG DRUG: Naltrexone hydrochloride, Naltrexone )

---

5 diseases

6. パーキンソン病

---

臨床試験数 : 2,586 / 薬物数 : 1,871 - (DrugBank : 354) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 205 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

10. シャルコー・マリー・トゥース病

---

臨床試験数 : 45 / 薬物数 : 34 - (DrugBank : 10) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 22 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,685 / 薬物数 : 1,932 - (DrugBank : 355) / 標的遺伝子数 : 263 - 標的パスウェイ数 : 237 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

96. クローン病

---

臨床試験数 : 2,737 / 薬物数 : 1,197 - (DrugBank : 240) / 標的遺伝子数 : 182 - 標的パスウェイ数 : 221 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

226. 間質性膀胱炎（ハンナ型）

---

臨床試験数 : 163 / 薬物数 : 158 - (DrugBank : 58) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 142 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries